SELL TO SCIENTISTS.

Industry Profile

Epigenomics and Chromatin Biology

Target researchers — Epigenomicists and chromatin biologists specializing in histone modification, DNA methylation, ATAC-seq, ChIP-seq, CUT and RUN, chromatin remodeling complexes, and small-molecule modulation of epigenetic writers, readers, and erasers

Epigenomics companies target chromatin-modifying enzymes—HATs, HDACs, methyltransferases—to reverse aberrant gene silencing in cancer and immune disorders. University chromatin biology labs are key IP sources for novel histone modification pathways, screening assays, and epigenetic biomarkers that companies incorporate into drug discovery programs.

$3.9B Market size
10 Key companies
6 Use cases

Key Companies

Constellation Pharmaceuticals MorphoSys EpiZyme Syndax Kymera Therapeutics C4 Therapeutics Imago BioSciences Prelude Therapeutics Active Motif EpigenomIQ Cellectar Biosciences Celldex Therapeutics

Use Cases

01

HDAC and DNMT inhibitor co-development

02

Epigenomic profiling CRO services

03

Chromatin remodeler target licensing

04

Degrader PROTAC epigenetic target access

05

Precision oncology biomarker development

06

ChIP-seq and ATAC-seq data analysis partnerships

Free to browse · subscribe to unlock the full dataset

See the full dataset.

Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.

Sign Up Free →
Get Started